Currently, the COVID-19 epidemic will mostly affect the group that has not been infected yet, which accounts for about 15 to 20 percent of the total population in China, said Professor Lu Mengji from the Institute for Virology of the University of Duisburg-Essen in Germany on Sunday.
The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use, which made it the second Chinese vaccine included in the WHO Emergency Use Listing after the previous one developed by another Chinese manufacturer Sinopharm.
World Insights: Chinese vaccines boost global fight against COVID-19 pandemic - China News sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.
2021-06-02 16:56 By: Xinhua
GENEVA, June 2 (Xinhua) The World Health Organization (WHO) on Tuesday validated China s CoronaVac vaccine for emergency use, the second Chinese vaccine approved by the WHO.
The validation means China s vaccines will play a greater role in helping the world eliminate the vaccine divide that is impeding global efforts to curb the COVID-19 pandemic.
Unlike some developed countries which are hoarding vaccines, China has been taking concrete steps to deliver on its promise to make Chinese vaccines a global public good, and implementing with practical actions the concept of a global community of health for all.